SEC Filing Details
Document Details
Form
Filing Date
Feb 7, 2024
Document Date
Jan 24, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Galectin Therapeutics Inc.
Issuer
GALECTIN THERAPEUTICS INC
Filer
SCHWARTZ ELISSA J.